Clinical Trial Update: Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the use of combined intravenous and intra-arterial chemotherapy to shrink unresectable cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Snippet

Sponsor: University of Zurich | Conditions: Cholangiocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED